MedKoo Cat#: 524618 | Name: Cgp 19984

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Cgp 19984 is a thiazolidinedione derivative that inhibits luteinizing hormone secretion and has antitumor effects. CGP 19984 significantly inhibited growth of the androgen-dependent Dunning R3327 rat prostate adenocarcinoma. The ability of CGP 19984 to suppress gonadal function and to inhibit tumor growth suggests that this drug may have potential clinical application in the treatment of both hormone-dependent and -independent prostate and breast cancers.

Chemical Structure

Cgp 19984
Cgp 19984
CAS#524618

Theoretical Analysis

MedKoo Cat#: 524618

Name: Cgp 19984

CAS#: 524618

Chemical Formula: C13H18N4NaO6PS2

Exact Mass:

Molecular Weight: 444.40

Elemental Analysis: C, 35.13; H, 4.08; N, 12.61; Na, 5.17; O, 21.60; P, 6.97; S, 14.43

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Cgp 19984; Cgp 19984; Cgp 19984.
IUPAC/Chemical Name
Phosphoric acid, monomethyl mono(3-methyl-2((5-methyl-3-(2-methyl-2-propenyl)-4-oxo-2-thiazolidinylidene)hydrazono)-4-oxo-5-thiazolidinyl) ester, sodium salt
InChi Key
NBLRJJYBVOILET-WTPNZJEDSA-M
InChi Code
InChI=1S/C13H19N4O6PS2.Na/c1-7(2)6-17-9(18)8(3)25-13(17)15-14-12-16(4)10(19)11(26-12)23-24(20,21)22-5;/h8,11H,1,6H2,2-5H3,(H,20,21);/q;+1/p-1/b14-12+,15-13-;/t8-,11+;/m1./s1
SMILES Code
[Na+].P(=O)(O[C@@H]1C(N(C(\S1)=N/N=C1\S[C@@H](C(N1CC(=C)C)=O)C)C)=O)(OC)[O-]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 444.40 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Shea WK, Black J, Ip MM. Short-term primary culture of rat prostate tumor epithelial cells on reconstituted basement membrane as a useful in vitro model to assess drug action on prostatic cancer: efficacy of the thiazolidinedione derivative CGP 19984. Prostate. 1989;15(2):157-70. Erratum in: Prostate 1990;16(2):185. PubMed PMID: 2798233. 2: Sylvester PW, Utz PJ, Ip MM. Effects of the thiazolidinedione derivative CGP 19984 on growth and endocrine function of the MtT-W10 transplantable mammosomatotropic pituitary tumor in female rats. Int J Cancer. 1988 Aug 15;42(2):289-94. PubMed PMID: 3403072. 3: Ip MM, Sylvester PW, Schenkel L. Antitumor efficacy in rats of CGP 19984, a thiazolidinedione derivative that inhibits luteinizing hormone secretion. Cancer Res. 1986 Apr;46(4 Pt 1):1735-40. PubMed PMID: 3948162.